News

Incisive Genetics Raises $12 Million CAD Financing in Expanded Seed Round

VANCOUVER, CANADA – June 27, 2022 – Incisive Genetics Inc. (“IG”), a privately held biotech company specializing in the research and development of...

READ MORE >>

Incisive Genetics Announces Closing of a $2.5 Million Seed Investment

The financing syndicate was led by investors Noel Hall and Sandra MacPherson of the MacHall group and Haig Farris, OC.

READ MORE >>

Announcing Formation of Scientific Board and Appointment of Dr. Michael R. Hayden as Chairperson

IG today announced the formation of its Scientific Advisory Board (SAB) and the appointment of Dr. Michael R. Hayden as chairperson.

READ MORE >>

Incisive Genetics Announces the Appointment of Dr. Kevin Chow as President

Key addition to Leadership Team brings more than two decades of industry experience in biotechnology corporate development and strategy.

READ MORE >>

Incisive Genetics Announces the Close of a $500,000 First Phase of a $2 Million Angel Investment

Biotech company IG, specializing in the research and development of a novel non-viral delivery platform for targeted CRISPR-based gene therapies.

READ MORE >>

IN THE MEDIA

No items found.
Contact Us
© Copyright 2021 Incisive Genetics Inc. All Rights Reserved